FDA greenlights telethermographic systems’ use for COVID-19 triage

The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis. Because fever is a common symptom of the virus, FDA says that telethermographic systems, which convert infrared radiation into body temperature measurement, can be deployed to use for initial triage at high-traffic areas, such as airports, businesses, warehouses and factories, as well as in settings where thermometers may be in short supply.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services May 31 released regulatory changes to the COVID-19 health care staff vaccination requirements and long-term…
#HealthCareInnovation Blog
In the fall of 2021, two years into the COVID-19 pandemic in the U.S., nearly 80% of adults said they had heard “at least one of eight different false…
Headline
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-…
Headline
The Centers for Medicare and Medicaid Services released a FAQ regarding Consolidated Appropriations Act changes for states redetermining Medicaid enrollee…
Headline
Telehealth Access for America, an AHA-supported campaign to protect patient access to critical telehealth services, urged Congress to make permanent certain…
Headline
The Department of Health and Human Services May 11 amended its Public Readiness and Emergency Preparedness Act declaration for COVID-19 to extend…